Search
for
Sort by
Research 511–540 of 1000+
- High circulating oestrone and low testosterone correlate with adverse clinical outcomes in men with advanced liver disease
- Spironolactone in the Treatment of Hirsutism
- Female pattern hair loss: A comprehensive review
- Delayed Puberty
- Finasteride-Induced Gynecomastia in a 62-Year-Old Man
- Care for Adolescents With Polycystic Ovary Syndrome: Development and Prescribing Patterns of a Multidisciplinary Clinic
- Gynecologic and andrologic dermatology and the metabolic syndrome
- Premature Graying, Balding, and Low Bone Mineral Density in Older Women and Men
- Characteristics of hair loss after COVID‐19: A systematic scoping review
- Dehydroepiandrosterone (DHEA) and Testosterone Concentrations in Human Hair after Chronic DHEA Supplementation
- Estrone Sulfate Source of Estrone and Estradiol Formation in Isolated Human Hair Roots: Identification of a Pathway Linked to Hair Growth Phase and Subject to Site-, Gender-, and Age-Related Modulations
- The Safety of Testosterone Therapy in Women
- Side-effects and possible complications of oral contraceptive drugs.
- Molecular Mechanisms Lead to Sex-Specific COVID-19 Prognosis and Targeted Therapies
- Bisphenol-A antagonizes the rapidly modulating effect of DHT on spinogenesis and long-term potentiation of hippocampal neurons
- Gender effects in allergology – Secondary publications and update
- Male, Female, Other: Transgender and the Impact in Primary Care
- Gynecomastia and Premature Thelarche
- Epigenetic Effects of Gender-Affirming Hormone Treatment: A Pilot Study of the ESR2 Promoter’s Methylation in AFAB People
- Dihydrotestosterone may contribute to the development of migraine headaches.
- AN ATTEMPT TO ASSESS THE MAGNITUDE OF ENDOGENOUS ANDROGEN PRODUCTION IN A CASE OF THE ADRENOGENITAL SYNDROME*
- Shedding light on cashmere goat hair follicle biology: from morphology analyses to transcriptomic landascape
- Testosterone Treatment in Women – An Overview
- Vulvar problems in elderly women
- Metabolic Effect at Six and Twelve Months of Cyproterone Acetate (2 mg) Combined with Ethinyl Estradiol (35 μg) in 31 Patients
- Preponderance of serum and intra-hepatic 5α-dihydrotestosterone in males with hepatocellular carcinoma despite low circulating androgen levels
- Effects of AiQingHua oil on microcirculation disturbance and alopecia mice model
- Hyperandrogenism-Insulin Resistance-Acanthosis Nigricans Syndrome
- Safety and efficacy of transdermal testosterone for treatment of hypoactive sexual desire disorder
- Drug safety evaluation of exemestane